...in the news

Displaying 1771 - 1780 of 7681 (10 per page)

Score	HS	BSN	CLB	EQT	IPO	M&A	IP	Date

BSD launches rectal cancer treatment study
								Sep 19, 2010
BSD Medical wins FDA clearance for ablation system, drums up $2.75 million
								Feb 13, 2013
From Space to Spinal Fusions: Interview with Amedica President and CEO Eric Olson
								Feb 12, 2014
A big year ahead for InfraRedX and its heart attack risk test
								Feb 12, 2014
Pharmacyclics wins 2nd FDA approval for blood cancer drug Imbruvica: Pharmacyclics Chairman and CEO Robert Duggan has more cancer targets in view for Imbruvica.
								Jan 6, 2010
Vignet Unveils Connected Health Services Platform for Mobile Wellness and Disease Management
								Feb 12, 2014
J&J, Pharmacyclics get CLL approval for Imbruvica: Expanded use should propel the drug toward its blockbuster destiny
								Nov 20, 2013
Pharmacyclics snags $50 million as cancer drug moves toward European approval
								Aug 29, 2013
Pharmacyclics Gets $75 Million as Fda Accepts Cancer Drug Filing
								Feb 13, 2014
Illumina and Yuri Milner will back a genomics startup incubator in San Francisco